2023 annual financial data
Ensysce Biosciences 2023 Net margin
Direct answer
Net margin was -475.71%.
Operating income was -10,718,000 USD and net income was -10,613,000 USD.
Operating cash flow was -10,779,982 USD.
Get free Ensysce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,231,000 USD
- Operating income
- -10,718,000 USD
- Net income
- -10,613,000 USD
- Operating cash flow
- -10,779,982 USD